Associate Professor of Health Care Policy, Harvard Medical School
Internal Medicine
Dr. Nancy L. Keating, MD
|
|
Give Review
Nancy L. Keating, MD practices Internal Medicine. She studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care She over the years received 1 awards: "Elected Member". Nancy Keating is a published physician. She has 102 papers published. The most current publication "ReCAP: Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer." She accepts Medicare payments and is listed with Medicare.gov.
Publications
- New Guidelines for Breast Cancer Screening in US Women.
- The role of families in decisions regarding cancer treatments.
- Oncologists' experiences with drug shortages.
- Racial/ethnic disparities in knowledge about one's breast cancer characteristics.
- Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer.
- Symptom prevalence in lung and colorectal cancer patients.
- Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer.
- Reprint of: Results from using a new dyadic-dependence model to analyze sociocentric physician networks.
- Samuel and keating respond.
- Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer.
- Developing and Evaluating Composite Measures of Cancer Care Quality.
- Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.
- Physician-reported barriers to referring cancer patients to specialists: Prevalence, factors, and association with career satisfaction.
- Did Changes in Drug Reimbursement After the Medicare Modernization Act Affect Chemotherapy Prescribing?
- Results from using a new dyadic-dependence model to analyze sociocentric physician networks.
- Evaluation of Breast Cancer Knowledge Among Health Promoters in Mexico Before and After Focused Training.
- Pain experiences among a population-based cohort of current, former, and never regular smokers with lung and colorectal cancer.
- Physicians' Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer.
- Drug plan design incentives among Medicare prescription drug plans.
- Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy.
- Physicians' Propensity To Discuss Prognosis Is Associated with Patients' Awareness of Prognosis for Metastatic Cancers.
- A systematic assessment of benefits and risks to guide breast cancer screening decisions.
- Effectiveness of Primary Androgen-Deprivation Therapy for Clinically Localized Prostate Cancer.
- Androgen deprivation therapy and cardiovascular harm: are all men created equal?
- Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study.
- Race by Sex Differences in Depression Symptoms and Psychosocial Service Use Among Non-Hispanic Black and White Patients With Lung Cancer.
- Physicians' Preferences for Hospice if They Were Terminally Ill and the Timing of Hospice Discussions With Their Patients.
- Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia.
- Patterns of Hospice Care Among Military Veterans and Non-veterans.
- The Impact of Out-of-Pocket Costs on the Use of Intrauterine Contraception Among Women With Employer-sponsored Insurance.
- Ultraviolet index and racial differences in prostate cancer incidence and mortality.
- Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
- Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer.
- Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
- The Impact of Emerging Safety and Effectiveness Evidence on the Use of Physician-administered Drugs: The Case of Bevacizumab for Breast Cancer.
- Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations.
- Expected years of life lost for six potentially preventable cancers in the United States.
- Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Co...
- Medical oncologists' perceptions of financial incentives in cancer care.
- Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy.
- Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer.
- Androgen-deprivation Therapy and Risk for Biliary Disease in Men with Prostate Cancer.
- Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.
- Tumor boards and the quality of cancer care.
- Effect of Massachusetts health insurance reform on mammography use and breast cancer stage at diagnosis.
- Variation in patient-sharing networks of physicians across the United States.
- Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era.
- Referrals for suspected hematologic malignancy: a survey of primary care physicians.
- Area-Level Variations in Cancer Care and Outcomes.
- Physician Patient-sharing Networks and the Cost and Intensity of Care in US Hospitals.
- Explaining racial differences in prostate cancer mortality.
- Understanding Variation in Primary Prostate Cancer Treatment Within the Veterans Health Administration.
- Providing Cancer Care: Individual or Team Sport?
- Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.
- Location of Cancer Surgery for Older Veterans with Cancer.
- Reasons for Choice of Referral Physician Among Primary Care and Specialist Physicians.
- Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.
- Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer.
- Reply to receipt of adjuvant breast cancer therapy in minority women.
- Quality of care for older patients with cancer in the veterans health administration versus the private sector: a cohort study.
- Mapping Physician Networks with Self-Reported and Administrative Data.
- A population-based assessment of specialty physician involvement in cancer clinical trials.
- Minimal social network effects evident in cancer screening behavior.
- The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
- Medicare reimbursement and prescribing hormone therapy for prostate cancer.
- Quality of cancer care among foreign-born and US-born patients with lung or colorectal cancer.
- Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health.
- Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles?
- End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector.
- Long and short hospice stays among nursing home residents at the end of life.
- Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity.
- National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.
- Employment among survivors of lung cancer and colorectal cancer.
- Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
- Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testost...
- Resident education and management of end-of-life care: the resident's perspective.
- Physician factors associated with discussions about end-of-life care.
- NIH State-of-the-Science Conference Statement: Enhancing Use and Quality of Colorectal Cancer Screening.
- Differences in clinical trial patient attributes and outcomes according to enrollment setting.
- Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
- Surgeons' volume of colorectal cancer procedures and collaborative decision-making about adjuvant therapies.
- Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.
- Financial status, employment, and insurance among older cancer survivors.
- Comparative effectiveness of minimally invasive vs open radical prostatectomy.
- The role of primary care physicians in cancer care.
- Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factors.
- Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
- Factors influencing changes in employment among women with newly diagnosed breast cancer.
- Discussions with physicians about hospice among patients with metastatic lung cancer.
- Ownership status and home health care performance.
- Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
- Physicians' experiences with BRCA1/2 testing in community settings.
- Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy.
- Randomized trial of $20 versus $50 incentives to increase physician survey response rates.
- Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
- Utilization and outcomes of minimally invasive radical prostatectomy.
- Rejections of drug claims for nursing home residents under Medicare Part D.
- Care in the months before death and hospice enrollment among older women with advanced breast cancer.
- Variation in patients' hospice costs.
- ReCAP: Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.
- Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Brigham Womens Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Elected Member
Education
-
Brigham and Women's Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
Brigham and Women's Faulkner Hospital -
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Brent A. Ragar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shereef M. Elnahal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman S. Harris Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi B. Patel, MD |
|
|
Dr. Narath Carlile, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica L. Taylor, MD |
|
|
Dr. Caroline Birks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lela Caros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard N. Winickoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garrett M. Chinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James B. Meigs, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jessica E. Viola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen Freund, MD
This Doctor is OpenDoctor Recommended.
|